Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
1. Product IngredientsThe chemical name of afatinib is N-{4-(3-chloro-4-fluoroph···【more】
Release date：2024-11-18Recommended：211
In a phase 1 study, sotorasib showed anticancer activity in patients with advanc···【more】
Release date：2024-11-15Recommended：172
According to NCCN guidelines, for patients with KRASG12C-mutated non-small cell ···【more】
Release date：2024-11-15Recommended：272
Cabobrutinib is a tyrosine kinase inhibitor that primarily targets MET, VEGFR an···【more】
Release date：2024-11-14Recommended：249
Pralsetinib is a selective RET kinase inhibitor indicated for the treatment of R···【more】
Release date：2024-11-14Recommended：237
Elacestrant, a non-steroidal small molecule, is an estrogen receptor (ER) antago···【more】
Release date：2024-11-13Recommended：236
Balversa is a small molecule inhibitor of fibroblast growth factor receptor (FGF···【more】
Release date：2024-11-13Recommended：242
Retinitis due to cytomegalovirus is indeed a serious eye infection that mainly a···【more】
Release date：2024-11-12Recommended：248
1. Targeted therapySpecific inhibitionAs a tyrosine kinase inhibitor, balversa s···【more】
Release date：2024-11-12Recommended：256
Capmatinib has shown significant efficacy in the treatment of non-small cell lun···【more】
Release date：2024-11-11Recommended：300
The neoadjuvant regimen of Pralsetinib is primarily based on its significant eff···【more】
Release date：2024-11-11Recommended：207
Fidaxomicinis a macrolide antibiotic developed by Optimer, which is mainly used ···【more】
Release date：2024-08-30Recommended：210
